Researchers identify genetic risk factors that contribute to the vulnerability and severity of pneumonia
Synthetic lung organoids provide a high throughput platform to identify new cellular targets of SARS-CoV-2
.jpg?fit=300%2C300&ssl=1 "Study supports ongoing phase 3 testing of the Ad26.COV2.S SARS-CoV-2 vaccine")
